Aperio Group’s HealthStream HSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$253K Sell
11,620
-10,748
-48% -$216K ﹤0.01% 2247
2020
Q3
$448K Buy
22,368
+3,266
+17% +$69.4K ﹤0.01% 1868
2020
Q2
$423K Buy
19,102
+103
+0.5% +$2.39K ﹤0.01% 1850
2020
Q1
$455K Buy
18,999
+10,686
+129% +$268K ﹤0.01% 1702
2019
Q4
$226K Buy
+8,313
New +$229K ﹤0.01% 2164
2019
Q3
Sell
-5,434
Closed -$141K 2515
2019
Q2
$141K Buy
+5,434
New +$143K ﹤0.01% 2293

Other funds holding HSTM

Aperio Group's HSTM Position: Q4 2020 in Review

Aperio Group reduced its HealthStream (HSTM) stake by 48% in Q4 2020, selling an estimated $216K and leaving 11,620 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #2247.

Aperio Group first reported a position in HSTM in Q2 2019 and has held it in 6 quarters since. The position peaked at $455K in Q1 2020. 149 funds tracked by Wall St. Rank hold HSTM as of Q4 2020.

  • Aperio Group held 11,620 shares of HealthStream worth $253K as of Q4 2020.
  • Aperio Group sold 10,748 HealthStream shares in Q4 2020, an estimated $216K.
  • HealthStream made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2247 holding.
  • Aperio Group first reported a position in HealthStream in Q2 2019 and has held it in 6 quarters since.
  • Aperio Group's HealthStream position peaked at $455K in Q1 2020.
  • 149 funds tracked by Wall St. Rank held HealthStream as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.